Current Research Interests
Dr. Blinder's main research interest is in ethnic disparities in survivorship outcomes among women treated for breast cancer. Dr. Blinder has conducted qualitative research on barriers to return to work among ethnically diverse breast cancer survivors in New York City. She is currently collaborating with colleagues at UCLA on a prospective longitudinal study of low-income uninsured or under-insured breast cancer survivors in California. She presented an analysis of employment outcomes in Latina and Caucasian participants in this study at the American Society of Clinical Oncology annual meeting in May 2009. Dr. Blinder received an MSKCC Cancer Survivorship Initiative grant (sponsored by Chanel) and a prepilot award through the NCI-funded CCNY/MSKCC Partnership (U54 CA137788) in 2009 to conduct a multi-center study of ethnic differences in the impact of breast cancer on employment status, financial situation, and quality of life. Additional research interests include ethnic disparities in breast cancer care and the financial impact of breast cancer on economically disadvantaged populations.
Selected Bibliography
- Gold HT, Hall MJ, Blinder V, Schackman BR. "Cost effectiveness of pharmacogenetic testing for UGT1A1 before irinotecan administration for metastatic colorectal cancer." Cancer 2009, 115(17):3858-3867.
- Elkin EB, Blinder V. Advances in Breast Cancer: Reducing Risk and Improving Health Outcomes. Perspectives in Public Health: Challenges for the 21st Century. Finkel, M.L. (editor). Santa Barbara, CA: Praeger Press. forthcoming 2010.
